Investigating plasma levels as biomarker for Alzheimer's disease
Monday, April 18, 2016 - 14:51
in Health & Medicine
The first detailed study of relationship between plasma levels of two amyloid beta peptides, cognitive function and the measures studying the size of brain, which shrinks with Alzheimer's disease.